Location History:
- Ciudad de la Habana, CU (2005 - 2014)
- La Habana, CU (2016)
Company Filing History:
Years Active: 2005-2016
Title: The Innovative Contributions of Jorge Victor Gavilondo Cowley
Introduction
Jorge Victor Gavilondo Cowley is a distinguished inventor based in Ciudad de la Habana, Cuba, known for his significant contributions to biotechnology and pharmacology. With five patents to his name, his work has focused primarily on developing innovative solutions for medical therapies, particularly in the field of oncology and vascular diseases.
Latest Patents
Gavilondo Cowley’s latest inventions include groundbreaking research on recombinant antibodies to vascular endothelial growth factor (VEGF). His invention describes human recombinant antibodies that specifically target human VEGF-A. These antibodies block the interaction with the VEGFR2 receptor and hinder its proliferative effects in vitro as well as its pro-angiogenic effects in vivo. The antibodies recognize a unique epitope on human VEGF-A that differs from previously reported ones and were engineered by combining one immunoglobulin light chain variable region with three heavy chain regions through mutagenesis techniques. Furthermore, Gavilondo Cowley has developed active antiangiogenic therapies using oligonucleotide and polypeptide sequences from the vascular permeability factor (VPF) family, aiming at treating various pathological conditions linked to increased angiogenesis. These include cancer, acute and chronic inflammatory diseases, infections, and diabetic retinopathies, among others.
Career Highlights
Throughout his career, Jorge Victor Gavilondo Cowley has held pivotal roles in reputable institutions such as the Center for Genetic Engineering and Biotechnology and the Molecular Immunology Center. His innovative research not only contributes to advancing therapeutic options but also reflects his dedication to addressing critical health challenges.
Collaborations
Gavilondo Cowley has had the privilege of collaborating with notable colleagues in the field, including Mónica Bequet Romero and Boris Ernesto Acevedo Castro. These partnerships have fostered an enriching environment for innovative research and development, enhancing the impact of their collective work on the scientific community.
Conclusion
Jorge Victor Gavilondo Cowley stands as a prominent figure in biotechnology and medicine, recognized for his innovative approaches to treatment and his commitment to improving healthcare outcomes. His patented inventions showcase a blend of creativity and scientific rigor, marking him as a significant contributor to the ongoing evolution of medical therapies.